Leopard. Conquer Time and Spaces.



Top Ten Property Investment Hotspots for 2008



Gazing into our crystal ball, this is a list of likely overseas property investment markets that should do well in 2008.


1. Thailand


Thailand has a two things going for it at the moment:

  • Weak currency. Even against the dollar, the baht is weak.
  • Weak property prices. The upcoming Thai elections and insecurity over the US sub-prime mortgage crash are causing a drop in prices, that make a very attractive proposition.


2. Morocco


Morocco is still a very undeveloped market and as far as we’re concerned, it looks very much like the Spain of a few years ago.

  • Property prices are very attractive compared to the E.U.
  • The low cost of living makes a luxury lifestyle a real possibility
  • The property boom is at the beginning of it’s cycle
  • Rental properties are experiencing 85% occupancy during the season
  • Capital growth is in excess of 15% year on year
  • Airfares, yacht club mooring fees and golf memberships are comparable to Spain thirty years ago



3. Abu Dhabi




Abu Dhabi seems intent on avoiding the mistakes made in Dubai, and is very much at the beginning of it’s upswing.



4. The Dominican Republic




There are a number of interesting new developments in the Dominican republic that bear a closer look. Once again, this is a very undeveloped emerging market that has a long way to go before prices come into line with the rest of the world.



5. Brazil





According to the Association of International Property Professionals (AIPP), Brazil is “fast becoming one of the property world’s talking points.” The property market in Brazil currently sits on the brink of a boom period; investment growth is inevitable, especially in locations by the sea and in north east Brazil. Many areas are being transformed into top class resorts with supporting infrastructures to boost the tourist industry.



6. India




India’s property market is booming. The difference is that India’s was long out of bounds to institutional investors, particularly foreigners. That changed recently with drastic alterations to the foreign investment rules.



7. Romania




Romania is now in 2nd place to Latvia as the fastest growing economy in Central Europe. Production & Manufacturing has moved down the road to Romania, Bulgaria, Czech Republic, Hungary, Slovakia, and these are all likely good investments in 2008.



8. Montenegro




Real estate in Montenegro is undervalued; the country has entered into a period of reform designed to bring economic growth and foreign investment, Montenegrins are aligning for EU accession, albeit with a few hurdles to manage yet, but, the country is beginning to attract growing overseas tourism interest.



9. Turkey






Due to recent changes in the Turkish martgage laws, Turkey look set for a sizable boom.



10. The U.S.A



takes the number ten spot. Although we see a way to go before the sub-prime mortgage crisis settles down, look to the States for some good investment opportunities in 2008.




 List of Global INVEST Opportunities



 Current Opportunities


Investing in Japan


Discover the advantages of doing business in Japan. Learn how to bring your business here and read about foreign firms operating successfully in Japan. Get information about Japan's individual regions and markets.


 Investment Opportunities in Romania


Arabian Oud is the leading oriental perfume chain in the world. Fragrance and beauty business is considered among the top trading industries in the world.  for franchise opportunities


Invest in Beirut, Dubai, Abu Dhabi, Qatar, Jordan, Saudi Arabia


Invest in Canada




Franchise Opportunities , Joint Ventures, Partnering, Exclusive Distribution ,Acquisitions in Real estate ,emerging sectors ,Biotech, , Medical Technology and Related Industries



   Commercialization Partner for Development of Human Heart Failure Detection Technology

Cambridge, Massachusetts (USA) biotechnology company is looking for a commercialization partner and funding assistance for the continuing development of Human Heart Failure Detection Technology. Our unique approach to developing this technology resides first in having clearly identified and categorized human tissue samples through access to full medical records and demographics. Our technology is based on a subtractive hybridization screening analysis (SSH). We have used this analysis approach as a screening tool to develop a focused heart failure microarray containing 1,143 differentially expressed genes. The company provides intellectual property, expertise in pre-clinical screening and testing of NCEs (both GLP and non-GLP), a large animal model for pre-clinical screening and testing of NCEs and our human heart failure as well as large animal model heart failure array to the partnership. Required assistance includes the later stage clinical use for patient enrollment in clinical trials and identification of responders and non-responders, as well as sharing the burden of any additional costs associated with intellectual property patents, regulatory filings, and marketing.

Interested parties call 313-610-0693


   Merger or Acquisition Target For Established Biotech, Pharma & Related

Southern New England biotechnology company is a merger or acquisition target for a biotech, pharma or related company with the capability to fully exploit the technological and market potential of company's platform technology and lead candidate. Target biotech company owns significant intellectual property (IP) for re-engineering biopharma proteins. Although multiple applications include targeted delivery of therapeutic agents and targeted molecular imaging (platform technology), the lead candidate for clinical development is a proprietary single-chain vascular endothelial growth factor (scVEGF) for imaging VEGF receptors in tumor vasculature. Target biotech company has a fully-equipped modern laboratory facility with existing sales including >$4 million in federal grants and a global client base for its existing products and services.

Interested parties call 313-610-0693


  Peptide & Peptidomimetic Therapeutics

Looking for a commercialization partner and funding assistance for the continuing development of peptide and peptide mimetic drugs. Existing drug candidates show promising applications as a vaccine or cancer adjuvant; antimicrobial agent for antibiotic resistant microorganisms; angiogenesis promotion for wound healing; and, in the treatment of Alzheimer's Disease (AD). Therapeutic agents have a strong intellectual property position. Required assistance includes preclinical and early Phase I/II clinical studies. Distribution and manufacturing arrangements also considered.


Interested parties call 313-610-0693



  Novel DNA & Protein Chips

Seeking a commercialization partner for the development and manufacture of pre-printed slides for DNA and related microarrays. Dendron based surface chemistry & nanotechnology has a strong intellectual property position with additional applications in affinity chromatography, immunoassays, biosensors and biochips. Company with strong market presence preferred.

Interested parties call 313-610-0693



  Marine Coatings & Antibiofilm Coatings

Looking for a commercialization partner and co-marketing partnership with leading manufacturers or suppliers of industrial coatings (marine coatings and anti-biofilms). Novel environmentally friendly bioadhesive based coating technology shows promise as a substitute for tributyltin (TBT) based coatings. Assistance required in the co-development and manufacture of coating formulations with broad-spectrum antibiotics. Will consider multiple arrangements for separate market segments.

Interested parties call 313-610-0693



   Manufacturing Facility for Acquisition

Private firm seeks to purchase manufacturing facility, U.S. location only at this time. The facility must include land, building(s) and equipment/machinery. Facilities equipped for biotech, pharmaceutical or medical device operations preferred. Closed plants and turnarounds will be considered. Please provide summary of the operation, type of industry and specific dollar values. Summary should include information on location, value of the building, value of the land, value of any equipment or machinery and amount of receivables.


Interested parties call 313-610-0693



  Hepatitis C Treatment

Private individual seeks technology and other investors to address the poorly served yet expanding hepatitis C market by developing novel medical treatments. The therapeutic market for hepatitis C (HCV), a blood-based viral infection, is estimated to be over $4 billion annually. The company is actively pursuing an additional $5 million for the development of its core technology and will consider acquisition or licensing synergistic technologies.


Interested parties call  313-610-0693








                                                                To Learn more about new  global opportunities

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter



Copyright © 2007 Wish International. All rights reserved.